| Age, years |
63.6±11.1 |
63.4±10.7 |
0.583 |
| Men |
838 (72.2) |
835 (71.6) |
0.746 |
| Body mass index, kg/m2
|
25.1±3.3 |
25.1±3.3 |
0.644 |
| Diabetes mellitus |
393 (33.9) |
384 (32.9) |
0.650 |
| Arterial hypertension |
706 (60.9) |
685 (58.7) |
0.307 |
| Current smoker |
306 (26.4) |
324 (27.8) |
0.327 |
| Dyslipidaemia |
625 (53.9) |
609 (52.2) |
0.437 |
| Previous percutaneous coronary intervention |
147 (12.7) |
135 (11.6) |
0.452 |
| Previous coronary artery bypass grafting |
10 (0.9) |
8 (0.7) |
0.803 |
| Previous myocardial infarction |
56 (4.8) |
60 (5.1) |
0.801 |
| Previous cerebrovascular accident |
83 (7.2) |
78 (6.7) |
0.710 |
| Atrial fibrillation |
47 (4.1) |
35 (3.0) |
0.389 |
| Clinical diagnosis for percutaneous coronary intervention |
Silent ischaemia |
65 (5.6) |
55 (4.7) |
0.448 |
| Stable angina |
313 (27.0) |
328 (28.1) |
| Unstable angina |
424 (36.6) |
424 (36.4) |
| Non-ST-segment elevation myocardial infarction |
257 (22.2) |
238 (20.4) |
| ST-segment elevation myocardial infarction |
101 (8.7) |
121 (10.4) |
| IVUS/OCT-guided |
273 (23.5) |
265 (22.7) |
0.672 |
| Total stent length per patient lesion, mm |
<35 |
747 (64.4) |
719 (61.6) |
0.177 |
| ≥35 |
413 (35.6) |
448 (38.4) |
| Min. stent diameter per patient, mm |
<3 |
541 (46.6) |
531 (45.5) |
0.611 |
| ≥3 |
619 (53.4) |
636 (54.5) |
| Target lesion per patient |
1 |
848 (73.1) |
854 (73.2) |
0.590 |
| 2 |
236 (20.3) |
246 (21.1) |
| 3 |
62 (5.3) |
59 (5.1) |
| >3 |
14 (1.2) |
8 (0.7) |
| Number per patient |
1.30 |
1.30 |
| Medication at discharge |
| Aspirin |
1,147 (99.0) |
1,155 (99.0) |
>0.999 |
| Clopidogrel |
961 (82.9) |
961 (82.4) |
0.759 |
| Ticagrelor |
140 (12.1) |
152 (13.0) |
0.532 |
| Prasugrel |
43 (3.7) |
39 (3.3) |
0.709 |
| Renin-angiotensin system inhibitors |
738 (63.7) |
737 (63.2) |
0.827 |
| Beta-blocker |
720 (62.2) |
744 (63.8) |
0.457 |
| Statin |
1,096 (94.6) |
1,099 (94.2) |
0.750 |
